Inventor · disambiguated record
Haoxuan Wang
Also filed as: WANG HAOXUAN
10 granted patents·6 pending applications·21 citations·filing 2021–2025
85Inventor score
Top patents by PatentIndex Score
16 records- 0194US11718617B2Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of useAMGEN INC·Filed 2022·Granted Aug 8, 2023·4 cites·30 claims
- 0294US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0393US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0493US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0592US11866446B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·7 cites·55 claims
- 0682US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 0781US12319691B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 0874US2025388574A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 0971US12421249B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 1071US12252489B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 1168US12240839B2Cyclobutyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Granted Mar 4, 2025·0 cites·14 claims
- 1265US2025171425A1Uses of cyclobutyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2025·Application pending·0 cites
- 1364US2021387978A1Cyclobutyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Application pending·0 cites
- 1460US2025136612A14',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1560US2025195483A1Spiro piperidine derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1656US2025084094A1Spirocyclic inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haoxuan Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →